Facts and Features

Synovate launches new Therapy Monitors in Psychoses

Synovate Healthcare plans to extend its leadership in Therapy Monitors - tracking what physicians prescribe to patients for specific diseases, and their perceptions of different drugs - to the new therapietic field of Pyschoses. Synovate Healthcare is already a well-established player in Therapy Monitors in oncology, auto-immune, antiviral, metabolics and central nervous system disorders. Synovate’s Psychosis Monitor will cover the treatment of patients diagnosed with Schizophrenia and Bipolar disorders.

The syndicated study will be conducted online bi-annually, and will cover doctor demographics, attitudinal data and patient records, and offer the potential to customise with additional ad hoc questionnaires. Initial waves of the Psychoses Therapy Monitor will cover the UK, France, Germany, Italy and Spain, with the US to follow soon after.